Literature DB >> 27407340

SUBTOTAL THYROIDECTOMY IN THE MANAGEMENT OF GRAVE'S DISEASE.

P J Vincent1, M K Garg2, Y Singh3, V P Bhalla4, S Datta5.   

Abstract

Treatment options for Grave's disease include radio-iodine ablation, which is the standard treatment in the USA, antithyroid drug therapy, which is popular in Japan, and surgery, which is commonly employed in Europe and India. There are very few reports about the outcome of surgery in Grave's disease in the Indian setting. Surgery for Grave's disease is an attractive option in under developed countries to cut short prolonged drug treatment, costly follow up and avoid the need for radio-isotope facilities for 1311 ablation. Aim of the present study was to assess the result of subtotal thyroidectomy in 32 cases of Grave's Disease referred for surgery by the endocrinologist in a teaching hospital. Patients were prepared for surgery with Lugol's iodine and propranalol. Subtotal thyroidectomy was performed by a standard technique, which included dissection and exposure of recurrent laryngeal nerves and parathyroid glands. Actual estimation of weight of the remnant gland was not part of the study. Duration of follow up ranged from 6 months to 4 years. 13 of 32 cases were males. Age ranged from 20 to 57 years. There was 1 death in the immediate post-operative period. There were no cases of permanent hypoparathyroidism or recurrent laryngeal nerve palsy. 1 patient developed temporary hypoparathyroidism. 1 patient developed recurrence of hyperthyroidism and 3 cases developed hypothyroidism all within 2 years of surgery. The study has demonstrated the safety and effectiveness of surgery for Grave's Disease in comparison to the reported high incidence of hypothyroidism following radio-iodine therapy and high recurrence rate after anti thyroid drug therapy.

Entities:  

Keywords:  Grave's Disease; Thyroidectomy

Year:  2011        PMID: 27407340      PMCID: PMC4925115          DOI: 10.1016/S0377-1237(01)80043-5

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  15 in total

1.  Should the primary treatment of hyperthyroidism be surgical?

Authors:  D A Linos; D Karakitsos; J Papademetriou
Journal:  Eur J Surg       Date:  1997-09

2.  Selection of patients for surgery in the management of thyrotoxicosis.

Authors:  M T Chiu; P C Soon; B K Ng
Journal:  Ann Acad Med Singapore       Date:  1993-07       Impact factor: 2.473

3.  Parathyroid preservation during thyroid surgery.

Authors:  A R Shaha; B M Jaffe
Journal:  Am J Otolaryngol       Date:  1998 Mar-Apr       Impact factor: 1.808

4.  Surgical treatment of Graves' disease: subtotal or total thyroidectomy?

Authors:  P Miccoli; P Vitti; T Rago; P Iacconi; L Bartalena; F Bogazzi; E Fiore; R Valeriano; L Chiovato; R Rocchi; A Pinchera
Journal:  Surgery       Date:  1996-12       Impact factor: 3.982

5.  Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.

Authors:  Y Kasuga; S Kobayashi; M Fujimori; K Shingu; K Asanuma; Y Hama; K Ito; M Maruyama; J Amano
Journal:  Eur J Surg       Date:  1998-03

Review 6.  Hyperthyroidism. Current treatment guidelines.

Authors:  N J Gittoes; J A Franklyn
Journal:  Drugs       Date:  1998-04       Impact factor: 9.546

7.  Effect of subtotal thyroidectomy on natural history of ophthalmopathy in Graves' disease.

Authors:  Y Abe; H Sato; M Noguchi; T Mimura; K Sugino; O Ozaki; H Yoshimura; K Ito
Journal:  World J Surg       Date:  1998-07       Impact factor: 3.352

8.  Recent trends in the management of Graves' hyperthyroidism in Japan: opinion survey results, especially on the combination therapy of antithyroid drug and thyroid hormone.

Authors:  T Mori; H Sugawa; S Kosugi; M Ueda; N Hai; A Matsuda
Journal:  Endocr J       Date:  1997-08       Impact factor: 2.349

9.  Clinical experience with a human thyroid cell bioassay for thyroid-stimulating immunoglobulin.

Authors:  B Rapoport; F S Greenspan; S Filetti; M Pepitone
Journal:  J Clin Endocrinol Metab       Date:  1984-02       Impact factor: 5.958

10.  Short-term triiodothyronine in prevention of temporary hypothyroidism after subtotal thyroidectomy for Graves' disease.

Authors:  T J Wilkin; A Gunn; T E Isles; J Crooks; J S Beck
Journal:  Lancet       Date:  1979-07-14       Impact factor: 79.321

View more
  1 in total

1.  A new method of subtotal thyroidectomy for Graves' disease leaving a unilateral remnant based on the upper pole.

Authors:  Yu Liu; Bin Liu; Rui-Lei Liu; Hua Jiang; Ze-Nan Huang; Yong Huang
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.